Co-managing laser cataract surgery

Article

Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta.

Associate Optometric Editor Katherine M. Mastrota, OD, offers her view on one panelist’s presentation during the special session “Refractive/Cataract Surgery: The Future Revealed” at the 90th annual SECO International meeting in Atlanta:

Former Wills Eye Hospital surgeon Tyrie Jenkins, MD, spoke about her perspective on femtosecond laser cataract surgery, the implications of laser cataract surgery and OD cataract surgery co-management as part of a panel.

Dr. Jenkins, who is based in Honolulu, is a proponent of OD/MD cataract surgery co-management. She reviewed cataract surgery from couching to what may become the standard in cataract surgery today, laser-assisted cataract surgery. Laser-assisted cataract surgery has the potential to improve refractive outcomes and reduce cataract complications by creating a precise corneal incision and capsulorhexis as well as pre-treating the natural lens for removal with less phacoemulsification power.

The femtosecond photodisruptive laser produces microscopic bubbles that have the ability to divide material at a molecular level with no heat production. Interestingly, Dr. Jenkins notes that patient adoption of laser-assisted cataract surgery, currently an upcharge, is at 45% in her practice.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.